www.bvsintegralidade.icict.fiocruz.br
Provided by Alexa ranking, www.bvsintegralidade.icict.fiocruz.br has ranked N/A in N/A and 3826441st on the world. It is hoted in N/A with IP address 157.86.16.30. The home page has 0 external link.
SiteTOP Score: 74174
SiteTOP Rank: 735396
Top keyword related from Search Engine of www.bvsintegralidade.icict.fiocruz.br
Traffic Ranks of www.bvsintegralidade.icict.fiocruz.br
Owner: |
N/A |
RANK: |
3826441 |
Country code: |
N/A |
Country name: |
N/A |
Rank on country: |
N/A |
Host: |
N/A |
Ip: |
157.86.16.30 |
Ref link: |
|
Extension: |
br |
Top URL related to www.bvsintegralidade.icict.fiocruz.br
-
1. Fundação Oswaldo Cruz (Fiocruz): Ciência e tecnologia em …
Link: https://portal.fiocruz.br/en
Description: WebA Fundação Oswaldo Cruz (Fiocruz) tem como objetivos promover a saúde e o desenvolvimento social, gerar e difundir conhecimento científico e tecnológico, ser um agente da cidadania.
DA: 5 PA: 80 MOZ Rank: 95
-
2. Oswaldo Cruz Foundation - Wikipedia
Link: https://en.wikipedia.org/wiki/Oswaldo_Cruz_Foundation
Description: WebThe Oswaldo Cruz Foundation (Portuguese Fundação Oswaldo Cruz, also known as FIOCRUZ) is a scientific institution for research and development in biological sciences located in Rio de Janeiro, Brazil; it is considered one of the world's main public health research institutions.
DA: 93 PA: 21 MOZ Rank: 44
-
3. The Foundation - Fundação Oswaldo Cruz (Fiocruz): Ciência e …
Link: https://portal.fiocruz.br/en/foundation
Description: WebThe Foundation. Promote health and social development, generate and disseminate scientific and technological knowledge, be an agent of citizenship. These are the concepts that guide the actions of the Oswaldo Cruz Foundation (Fiocruz), under the Ministry of Health, the most prominent institution of science and technology in health in Latin America.
DA: 88 PA: 19 MOZ Rank: 81
-
4. Fiocruz releases first 100% Brazilian COVID-19 vaccine
Link: https://portal.fiocruz.br/en/news/fiocruz-releases-first-100-brazilian-covid-19-vaccine
Description: WebFeb 22, 2022 · 22/02/2022. Fiocruz News Agency. Share: The Oswaldo Cruz Foundation (Fiocruz), through the Immunobiological Technology Institute (Biomanguinhos), provides the first doses of the COVID-19 vaccine (recombinant) produced with the national Active Pharmaceutical Ingredient (API).
DA: 80 PA: 95 MOZ Rank: 64
-
5. Fiocruz develops new vaccines to fight COVID-19
Link: https://portal.fiocruz.br/en/news/fiocruz-develops-new-vaccines-fight-covid-19
Description: WebJun 4, 2021 · It will be a vaccine 100% produced in Brazil. But Fiocruz continues, in a complementary way, to support the development of other projects leading to new immunizers against COVID-19.
DA: 85 PA: 25 MOZ Rank: 19
-
6. Research and teaching - Fundação Oswaldo Cruz (Fiocruz): …
Link: https://portal.fiocruz.br/en/research-and-teaching
Description: WebFiocruz is the main institution non-university on training and qualification of human resources for the Unified Health System (SUS) and for science and technology in Brazil. It has 18 programs for post-graduate studies in several areas, a technical school and several programs in the broad sense.
DA: 57 PA: 35 MOZ Rank: 12
-
7. Who we are - Bio-Manguinhos/Fiocruz || Public Health Innovation
Link: https://www.bio.fiocruz.br/index.php/en-us/about-us-bio/who-we-are
Description: WebMay 16, 2022 · Twitter. The Institute of Technology on Immunobiologicals (Bio-Manguinhos) is the Oswaldo Cruz Foundation (Fiocruz) unit responsible for research, innovation, technological development and the production of vaccines, in vitro diagnostic kits and biopharmaceuticals aimed at primarily meeting the demands of national public health.
DA: 15 PA: 11 MOZ Rank: 87
-
8. Production and innovation - Fundação Oswaldo Cruz (Fiocruz): …
Link: https://portal.fiocruz.br/en/production-and-innovation
Description: WebInnovation Portfolio. One of Fiocruz’s main missions is manufacturing strategic products for the Brazilian Unified Public Health System (SUS). With one of the largest public pharmaceutical laboratories in the country - the Drug Technology Institute (Farmanguinhos) - Fiocruz contributes with nearly 40% of the drug purchased by the Ministry of ...
DA: 46 PA: 71 MOZ Rank: 89
-
9. mrna-vaccine - Bio-Manguinhos/Fiocruz || Public Health Innovation
Link: https://www.bio.fiocruz.br/index.php/en-us/mrna-vaccine
Description: WebMay 18, 2022 · The development of a Fiocruz mRNA vaccine is a fundamental step for Brazil to hold the technological mastery of two fundamental platforms for the advancement of development of immunobiologicals. With this project and the support of WHO, we are reaffirming our commitment to science and technology at the service of the population”.
DA: 83 PA: 45 MOZ Rank: 100
-
10. The Fiocruz response to the COVID-19 • Fiocruz
Link: https://fiocruz.tghn.org/coronavirus/
Description: WebThe Fiocruz response to the COVID-19. Fiocruz is the reference institution in Brazil for testing the novel coronavirus (SARS-2-COV) and has been working closely with the country´s Ministry of Health (MoH) to ensure timely and reliable diagnostic and response.
DA: 89 PA: 4 MOZ Rank: 84